table of content
1 Study Coverage
1.1 Anti-Infective Vaccines Product Introduction
1.2 Global Anti-Infective Vaccines Outlook 2017 VS 2022 VS 2028
1.2.1 Global Anti-Infective Vaccines Sales in US$ Million for the Year 2017-2028
1.2.2 Global Anti-Infective Vaccines Sales in Volume for the Year 2017-2028
1.3 United States Anti-Infective Vaccines Outlook 2017 VS 2022 VS 2028
1.3.1 United States Anti-Infective Vaccines Sales in US$ Million for the Year 2017-2028
1.3.2 United States Anti-Infective Vaccines Sales in Volume for the Year 2017-2028
1.4 Anti-Infective Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.4.1 The Market Share of United States Anti-Infective Vaccines in Global, 2017 VS 2022 VS 2028
1.4.2 The Growth Rate of Anti-Infective Vaccines Market Size, United States VS Global, 2017 VS 2022 VS 2028
1.5 Anti-Infective Vaccines Market Dynamics
1.5.1 Anti-Infective Vaccines Industry Trends
1.5.2 Anti-Infective Vaccines Market Drivers
1.5.3 Anti-Infective Vaccines Market Challenges
1.5.4 Anti-Infective Vaccines Market Restraints
1.6 Study Objectives
1.7 Years Considered
2 Market by Type
2.1 Anti-Infective Vaccines Market Segment by Type
2.1.1 Inactivated Vaccines
2.1.2 Conjugate Vaccines
2.1.3 Live/attenuated Vaccines
2.2 Global Anti-Infective Vaccines Market Size by Type
2.2.1 Global Anti-Infective Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.2.2 Global Anti-Infective Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.2.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
2.3 United States Anti-Infective Vaccines Market Size by Type
2.3.1 United States Anti-Infective Vaccines Sales in Value, by Type (2017, 2022 & 2028)
2.3.2 United States Anti-Infective Vaccines Sales in Volume, by Type (2017, 2022 & 2028)
2.3.3 United States Anti-Infective Vaccines Average Selling Price (ASP) by Type (2017, 2022 & 2028)
3 Market by Application
3.1 Anti-Infective Vaccines Market Segment by Application
3.1.1 Bacterial Diseases
3.1.2 Viral Diseases
3.2 Global Anti-Infective Vaccines Market Size by Application
3.2.1 Global Anti-Infective Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.2.2 Global Anti-Infective Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 Global Anti-Infective Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
3.3 United States Anti-Infective Vaccines Market Size by Application
3.3.1 United States Anti-Infective Vaccines Sales in Value, by Application (2017, 2022 & 2028)
3.3.2 United States Anti-Infective Vaccines Sales in Volume, by Application (2017, 2022 & 2028)
3.3.3 United States Anti-Infective Vaccines Average Selling Price (ASP) by Application (2017, 2022 & 2028)
4 Global Anti-Infective Vaccines Competitor Landscape by Company
4.1 Global Anti-Infective Vaccines Market Size by Company
4.1.1 Top Global Anti-Infective Vaccines Manufacturers Ranked by Revenue (2021)
4.1.2 Global Anti-Infective Vaccines Revenue by Manufacturer (2017-2022)
4.1.3 Global Anti-Infective Vaccines Sales by Manufacturer (2017-2022)
4.1.4 Global Anti-Infective Vaccines Price by Manufacturer (2017-2022)
4.2 Global Anti-Infective Vaccines Concentration Ratio (CR)
4.2.1 Anti-Infective Vaccines Market Concentration Ratio (CR) (2017-2022)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Anti-Infective Vaccines in 2021
4.2.3 Global Anti-Infective Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Anti-Infective Vaccines Manufacturing Base Distribution, Product Type
4.3.1 Global Anti-Infective Vaccines Manufacturers, Headquarters and Distribution of Producing Region
4.3.2 Manufacturers Anti-Infective Vaccines Product Type
4.3.3 Date of International Manufacturers Enter into Anti-Infective Vaccines Market
4.4 Manufacturers Mergers & Acquisitions, Expansion Plans
4.5 United States Anti-Infective Vaccines Market Size by Company
4.5.1 Top Anti-Infective Vaccines Players in United States, Ranked by Revenue (2021)
4.5.2 United States Anti-Infective Vaccines Revenue by Players (2020, 2021 & 2022)
4.5.3 United States Anti-Infective Vaccines Sales by Players (2020, 2021 & 2022)
5 Global Anti-Infective Vaccines Market Size by Region
5.1 Global Anti-Infective Vaccines Market Size by Region: 2017 VS 2022 VS 2028
5.2 Global Anti-Infective Vaccines Market Size in Volume by Region (2017-2028)
5.2.1 Global Anti-Infective Vaccines Sales in Volume by Region: 2017-2022
5.2.2 Global Anti-Infective Vaccines Sales in Volume Forecast by Region (2023-2028)
5.3 Global Anti-Infective Vaccines Market Size in Value by Region (2017-2028)
5.3.1 Global Anti-Infective Vaccines Sales in Value by Region: 2017-2022
5.3.2 Global Anti-Infective Vaccines Sales in Value by Region: 2023-2028
6 Segment in Region Level & Country Level
6.1 North America
6.1.1 North America Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.1.2 North America Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.1.3 U.S.
6.1.4 Canada
6.2 Asia-Pacific
6.2.1 Asia-Pacific Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.2.2 Asia-Pacific Anti-Infective Vaccines Market Facts & Figures by Region (2017, 2022 & 2028)
6.2.3 China
6.2.4 Japan
6.2.5 South Korea
6.2.6 India
6.2.7 Australia
6.2.8 Taiwan
6.2.9 Indonesia
6.2.10 Thailand
6.2.11 Malaysia
6.2.12 Philippines
6.3 Europe
6.3.1 Europe Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.3.2 Europe Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.3.3 Germany
6.3.4 France
6.3.5 U.K.
6.3.6 Italy
6.3.7 Russia
6.4 Latin America
6.4.1 Latin America Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.4.2 Latin America Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.4.3 Mexico
6.4.4 Brazil
6.4.5 Argentina
6.5 Middle East and Africa
6.5.1 Middle East and Africa Anti-Infective Vaccines Market Size YoY Growth 2017-2028
6.5.2 Middle East and Africa Anti-Infective Vaccines Market Facts & Figures by Country (2017, 2022 & 2028)
6.5.3 Turkey
6.5.4 Saudi Arabia
6.5.5 UAE
7 Company Profiles
7.1 Emergent BioDefense Operations Lansing Inc.
7.1.1 Emergent BioDefense Operations Lansing Inc. Corporation Information
7.1.2 Emergent BioDefense Operations Lansing Inc. Description and Business Overview
7.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.1.4 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Products Offered
7.1.5 Emergent BioDefense Operations Lansing Inc. Recent Development
7.2 Sanofi Pasteur
7.2.1 Sanofi Pasteur Corporation Information
7.2.2 Sanofi Pasteur Description and Business Overview
7.2.3 Sanofi Pasteur Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.2.4 Sanofi Pasteur Anti-Infective Vaccines Products Offered
7.2.5 Sanofi Pasteur Recent Development
7.3 Merck & Co.
7.3.1 Merck & Co. Corporation Information
7.3.2 Merck & Co. Description and Business Overview
7.3.3 Merck & Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.3.4 Merck & Co. Anti-Infective Vaccines Products Offered
7.3.5 Merck & Co. Recent Development
7.4 MedImmune LLC
7.4.1 MedImmune LLC Corporation Information
7.4.2 MedImmune LLC Description and Business Overview
7.4.3 MedImmune LLC Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.4.4 MedImmune LLC Anti-Infective Vaccines Products Offered
7.4.5 MedImmune LLC Recent Development
7.5 Novartis Vaccines
7.5.1 Novartis Vaccines Corporation Information
7.5.2 Novartis Vaccines Description and Business Overview
7.5.3 Novartis Vaccines Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.5.4 Novartis Vaccines Anti-Infective Vaccines Products Offered
7.5.5 Novartis Vaccines Recent Development
7.6 Diagnostics Ltd.
7.6.1 Diagnostics Ltd. Corporation Information
7.6.2 Diagnostics Ltd. Description and Business Overview
7.6.3 Diagnostics Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.6.4 Diagnostics Ltd. Anti-Infective Vaccines Products Offered
7.6.5 Diagnostics Ltd. Recent Development
7.7 Intercell Biomedical
7.7.1 Intercell Biomedical Corporation Information
7.7.2 Intercell Biomedical Description and Business Overview
7.7.3 Intercell Biomedical Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.7.4 Intercell Biomedical Anti-Infective Vaccines Products Offered
7.7.5 Intercell Biomedical Recent Development
7.8 MassBiologics
7.8.1 MassBiologics Corporation Information
7.8.2 MassBiologics Description and Business Overview
7.8.3 MassBiologics Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.8.4 MassBiologics Anti-Infective Vaccines Products Offered
7.8.5 MassBiologics Recent Development
7.9 Barr Labs, Inc.
7.9.1 Barr Labs, Inc. Corporation Information
7.9.2 Barr Labs, Inc. Description and Business Overview
7.9.3 Barr Labs, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.9.4 Barr Labs, Inc. Anti-Infective Vaccines Products Offered
7.9.5 Barr Labs, Inc. Recent Development
7.10 Organon Teknika Co.
7.10.1 Organon Teknika Co. Corporation Information
7.10.2 Organon Teknika Co. Description and Business Overview
7.10.3 Organon Teknika Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.10.4 Organon Teknika Co. Anti-Infective Vaccines Products Offered
7.10.5 Organon Teknika Co. Recent Development
7.11 GlaxoSmithKline Biologicals
7.11.1 GlaxoSmithKline Biologicals Corporation Information
7.11.2 GlaxoSmithKline Biologicals Description and Business Overview
7.11.3 GlaxoSmithKline Biologicals Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.11.4 GlaxoSmithKline Biologicals Anti-Infective Vaccines Products Offered
7.11.5 GlaxoSmithKline Biologicals Recent Development
7.12 CSL Ltd.
7.12.1 CSL Ltd. Corporation Information
7.12.2 CSL Ltd. Description and Business Overview
7.12.3 CSL Ltd. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.12.4 CSL Ltd. Products Offered
7.12.5 CSL Ltd. Recent Development
7.13 ID Biomedical Co.
7.13.1 ID Biomedical Co. Corporation Information
7.13.2 ID Biomedical Co. Description and Business Overview
7.13.3 ID Biomedical Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.13.4 ID Biomedical Co. Products Offered
7.13.5 ID Biomedical Co. Recent Development
7.14 Protein Sciences Co.
7.14.1 Protein Sciences Co. Corporation Information
7.14.2 Protein Sciences Co. Description and Business Overview
7.14.3 Protein Sciences Co. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.14.4 Protein Sciences Co. Products Offered
7.14.5 Protein Sciences Co. Recent Development
7.15 Wyeth Pharmaceuticals, Inc.
7.15.1 Wyeth Pharmaceuticals, Inc. Corporation Information
7.15.2 Wyeth Pharmaceuticals, Inc. Description and Business Overview
7.15.3 Wyeth Pharmaceuticals, Inc. Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.15.4 Wyeth Pharmaceuticals, Inc. Products Offered
7.15.5 Wyeth Pharmaceuticals, Inc. Recent Development
7.16 Berna Biotech
7.16.1 Berna Biotech Corporation Information
7.16.2 Berna Biotech Description and Business Overview
7.16.3 Berna Biotech Anti-Infective Vaccines Sales, Revenue and Gross Margin (2017-2022)
7.16.4 Berna Biotech Products Offered
7.16.5 Berna Biotech Recent Development
8 Industry Chain and Sales Channels Analysis
8.1 Anti-Infective Vaccines Industry Chain Analysis
8.2 Anti-Infective Vaccines Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Anti-Infective Vaccines Distributors
8.3 Anti-Infective Vaccines Production Mode & Process
8.4 Anti-Infective Vaccines Sales and Marketing
8.4.1 Anti-Infective Vaccines Sales Channels
8.4.2 Anti-Infective Vaccines Distributors
8.5 Anti-Infective Vaccines Customers
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
